Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocugen (OCGN) Equity Average (2016 - 2025)

Historic Equity Average for Ocugen (OCGN) over the last 11 years, with Q3 2025 value amounting to $3.3 million.

  • Ocugen's Equity Average fell 8855.92% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 8855.92%. This contributed to the annual value of $35.1 million for FY2024, which is 3871.75% down from last year.
  • Ocugen's Equity Average amounted to $3.3 million in Q3 2025, which was down 8855.92% from $9.5 million recorded in Q2 2025.
  • Ocugen's Equity Average's 5-year high stood at $116.0 million during Q2 2022, with a 5-year trough of $3.3 million in Q3 2025.
  • In the last 5 years, Ocugen's Equity Average had a median value of $54.5 million in 2023 and averaged $59.0 million.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 66958.75% in 2021, then crashed by 8855.92% in 2025.
  • Quarter analysis of 5 years shows Ocugen's Equity Average stood at $101.5 million in 2021, then decreased by 21.32% to $79.8 million in 2022, then crashed by 43.4% to $45.2 million in 2023, then dropped by 22.25% to $35.1 million in 2024, then crashed by 90.63% to $3.3 million in 2025.
  • Its Equity Average was $3.3 million in Q3 2025, compared to $9.5 million in Q2 2025 and $22.8 million in Q1 2025.